← Leaderboards
Karunya Kumar Kandimalla
Florida Agricultural And Mechanical Univ
$1,341,282
Attributed
$3,067,955
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $853.9K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,067,955 · 3
By mechanism
R01$2,998,051 · 2
S06$69,904 · 1
Top collaborators
- Val John Lowe4 shared
- Carlos Fernandez-Granda3 shared
- Mikel Hernaez3 shared
- Krishna Rani Kalari3 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseasePathway InteractionsBrainComplexCerebrovascularS Disease PatientImpairmentMolecularPathologicImageBrain ParenchymaEndotheliumAging PopulationAmyloid Beta-ProteinEndocytosisLabelUptakeApp-Ps1Diabetes MellitusDb/Db MouseDefectDown-RegulationBlood-Brain Barrier Function
Grant awards (8)
Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrier$478,190
R01 · FY2025 · NS · contact PI
CRCNS: Deep Learning to Discover Neurovascular Disruptions in Alzheimer's Disease$289,769
R01 · FY2025 · AG · contact PI
Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrier$529,773
R01 · FY2024 · NS · contact PI
CRCNS: Deep Learning to Discover Neurovascular Disruptions in Alzheimer's Disease$296,661
R01 · FY2024 · AG · contact PI
Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrier$529,773
R01 · FY2023 · NS · contact PI
CRCNS: Deep Learning to Discover Neurovascular Disruptions in Alzheimer's Disease$324,162
R01 · FY2023 · AG · contact PI
Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrier$549,723
R01 · FY2022 · NS · contact PI
Uptake Mechanisms and Degradation of Amyloid Beta Protein in Neurons (pilot)$69,904
S06 · FY2007 · GM · contact PI